Cargando…
Therapeutic activity of sarpogrelate and dopamine D(2) receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes
BACKGROUND: Dopamine D(2) receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia. An affiliation was found between the initiation of myocardial injury ailment and long term treatment with dopamine D(2) agonist...
Autores principales: | Fouad Shalaby, Mohammed Ahmed, Abd El Latif, Hekma A., El Yamani, Mohamed, Galal, May Ahmed, Kamal, Sherifa, Sindi, Ikhlas, Masaood, Raneem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547108/ https://www.ncbi.nlm.nih.gov/pubmed/34702339 http://dx.doi.org/10.1186/s40360-021-00526-6 |
Ejemplares similares
-
Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
por: Fouad Shalaby, Mohammed, et al.
Publicado: (2021) -
Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647]
por: Shalaby, Mohammed Fouad, et al.
Publicado: (2022) -
Aspirination of α-Aminoalcohol (Sarpogrelate M1)
por: Park, Sunhwa, et al.
Publicado: (2016) -
Suppression of high lipid diet induced by atherosclerosis sarpogrelate
por: Xu, Yan-Jun, et al.
Publicado: (2012) -
Arabic gum ameliorates systemic modulation in Alloxan monohydrate-induced diabetic rats
por: Ibrahim, Rasha Mohammed, et al.
Publicado: (2023)